Experimental drug could treat dyskinesia in people with Parkinson’s
March 2, 2020Sales and Marketing Parkinson's, Parkinson's disease, dyskinesia, spasms
Results from a new study researching treatment for dyskinesia has offered hope that it may be treatable in people with …
Takeda’s subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative colitis and Crohn’s
February 28, 2020Medical Communications, Sales and Marketing CHMP, EMA, Takeda, vedolizumab
Takeda’s subcutaneous formulation of its gut-selective biologic vedolizumab has secured recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal …
Top Ten most popular articles on Pharmafile.com this week
February 28, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus
The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …
Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting
February 28, 2020Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma
UK-based Acacia Pharma has secured its first US approval with the FDA’s decision to authorise Barhemsys (amisulpride injection) for the …
First coronavirus case confirmed in Wales as number of infected in Britain rises to 19
February 28, 2020Medical Communications British Coronavirus, Chinese Coronavirus, Wales coronavirus, Wuhan Coronavirus, coronavirus
A person has been diagnosed with coronavirus in Wales, with the number of infected continuing to rise as numerous sporting …
E. coli strain in the gut may increase risk of bowel cancer, new study finds
February 28, 2020Medical Communications Cancer, E. coli, bowel cancer, bowels, cancer research, e coli, oncology
A type of E. coli infection may increase a person’s chance of developing bowel cancer, according to a new study …
The March 2020 issue of Pharmafocus is available to read free online now!
February 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes
The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
FDA advisory committee narrowly backs Eli Lilly’s Cyramza combo for metastatic EGFR+ NSCLC
February 27, 2020Sales and Marketing Eli Lilly, FDA, cyramza, pharms
Eli Lilly’s Cyramza (ramucirumab) has edged closer to US approval after it scored a recommendation from the FDA’s Oncologic Drugs …
NICE recommends Celgene’s Revlimid combo for follicular lymphoma
February 27, 2020Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma
NICE has chosen to recommend Celgene’s Revlimid (lenalidomide) for use on the NHS, it has emerged, alongside Genentech’s Rituxan (rituximab), …
Female participation up in 2019 US clinical trials, but minority representation down
February 27, 2020Medical Communications, Research and Development FDA, clinical trials, pharma
The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …
US Judge rules that a decade of unpublished trial results must be made public
February 27, 2020Medical Communications, Research and Development FDA, US, clinical trials, pharma
A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …
First US coronavirus trial launched into Gilead’s remdesivir
February 26, 2020Research and Development FDA, Gilead, US, coronavirus, pharma
The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …
Takeda acquires PvP Biologics after successful Phase 1 study of Celiac Disease treatment
February 26, 2020Research and Development Celiac, PvP, Takeda, phase 1, phase III
Takeda has acquired PvP Biologics following the conclusion of a Phase 1 study of the investigational medicine TAK-062 for the …
Global cases of coronavirus rise, as first US soldier in South Korea tests positive for the virus
February 26, 2020Research and Development
The number of global cases of COVID-19 continues to rise as several nations work to contain outbreaks, in particular South …
NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma
February 26, 2020Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche
It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
New Johnson & Johnson study aiming to add stroke detection to Apple Watch
February 26, 2020Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke
Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …
Scotland’s life sciences sector on track to break $8 billion by 2025
February 25, 2020Manufacturing and Production, Sales and Marketing Scotland, UK, life sciences, pharma
A new report from the Scottish Government has revealed that the country’s life sciences sector is on track to breeze …
Austerity policies blamed as English life expectancy stalls for first time in a century
February 25, 2020Manufacturing and Production England, NHS England, UCL, austerity, life expectancy
A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …
FDA greenlights first oral, daily, non-statin therapy for lowering LDL-Cholesterol
February 25, 2020Manufacturing and Production, Sales and Marketing Esperion, FDA, Nexletol, pharma
Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …
World’s second largest API company to be created by Sanofi
February 25, 2020Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
